The benefits of bispecific antibodies over CAR-T cell therapy in lymphoma
Chan Yoon Cheah • 9 Dec 2022
Targeted Antibody Mogamulizumab Superior to Vorinostat for Previously Treated CTCL
Youn H. Kim • 10 Dec 2017
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.